Md. biotech delivers doses of anthrax vaccine to HHS

[Guest guest]

Md. biotech delivers doses of anthrax vaccine to HHS

http://washington.bizjournals.com/washington/stories/2006/12/11/daily50.html

Washington Business Journal - December 14, 2006

by Neil Adler

Staff Reporter

Emergent BioSolutions, which sells the only vaccine to protect against anthrax

that is licensed by the Food and Drug Administration, says it has completed the

delivery of more than 3 million doses of the vaccine to the Department of Health

and Human Services.

The roughly 3 million doses, representing revenue of about $75 million to the

company, are part of a $120 million contract awarded in May of this year by HHS

to Gaithersburg-based Emergent for 5 million doses, to be delivered by May 31,

2007, that will go into the country's strategic national stockpile.

Under this contract, Emergent has delivered about 4 million doses

and expects to supply the balance during the first quarter of next year, the

company says.

In total, Emergent now has supplied more than 9 million doses of the vaccine,

called BioThrax, to HHS. The company won a $123 million contract in May 2005 to

supply an initial 5 million doses.

Emergent (NYSE: EBS), which recently went public with its stock, is competing

with a handful of biotech and pharmaceutical companies developing anthrax drugs

and vaccines for the U.S. government. These competitors include Rockville-based

Human Genome Sciences (NASDAQ: HGSI).

Randi J. Airola, © 517-819-5926

http://military-biodefensevaccines.org

To receive MBVP E-news: http://military-biodefensevaccines.org click on MBVP

Chat List and join. The Chat List provides biodefense information and allows

subscribers to interact with one another. This is a public domain. Opinions

expressed by individuals are the responsibility of the individual.

The MBVP Chat list is a free service of the National Vaccine Information Center

(NVIC), which is a non-profit (501C3) educational organization. Donations are

tax deductible as provided under law. NVIC does not receive Government

subsidies. To support the MBVP of NVIC, go to

http://www.nvic.org/makingcashdonations.htm and become a member of NVIC.

NVIC publishes a free E-News newsletter with daily analysis and commentary by

Co-Founder/President Barbara Loe Fisher on infectious diseases and vaccine

research, regulation, policymaking, legislation, and informed consent issues. To

receive NVIC E-news: http://www.nvic.org and sign up.